Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Gross

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Oncotarget|October 6, 2015
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibitionJohn Paul Shen, Rohith Srivas, Andrew Gross, et al.
Bioinformatics (Oxford, England)|May 29, 2019
ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regionsEgor Dolzhenko, Viraj Deshpande, Felix Schlesinger, et al.
Nature Communications|July 26, 2022
An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseasesMallory J Owen, Sebastien Lefebvre, Christian Hansen, et al.
The New England Journal of Medicine|October 23, 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre-Antoine Juge, Joyce S Lee, Esther Ebstein, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Oncotarget|October 6, 2015
Chemogenetic profiling identifies RAD17 as synthetically lethal with checkpoint kinase inhibitionJohn Paul Shen, Rohith Srivas, Andrew Gross, et al.
Bioinformatics (Oxford, England)|May 29, 2019
ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regionsEgor Dolzhenko, Viraj Deshpande, Felix Schlesinger, et al.
Nature Communications|July 26, 2022
An automated 13.5 hour system for scalable diagnosis and acute management guidance for genetic diseasesMallory J Owen, Sebastien Lefebvre, Christian Hansen, et al.
The New England Journal of Medicine|October 23, 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre-Antoine Juge, Joyce S Lee, Esther Ebstein, et al.
Pageof 5